Results 31 to 40 of about 136,697 (349)

COVID‐19: A new barrier to treatment for opioid use disorder in the emergency department

Journal of the American College of Emergency Physicians Open, 2021
Objective Start Treatment and Recover (STAR) is an emergency department (ED) program that expands access to medication for opioid use disorder by identifying patients with opioid use disorder and offering ED‐initiated buprenorphine/naloxone and rapid ...
Warren Grunvald, Ramsey Herrington, Roz King, Miles Lamberson, Scott Mackey, Sanchit Maruti, Richard Rawson, Daniel Wolfson   +7 more
doaj   +1 more source

Nociceptin attenuates the escalation of oxycodone self-administration by normalizing CeA-GABA transmission in highly addicted rats. [PDF]

, 2020
Approximately 25% of patients who are prescribed opioids for chronic pain misuse them, and 5 to 10% develop an opioid use disorder. Although the neurobiological target of opioids is well known, the molecular mechanisms that are responsible for the ...
Carrette, Lieselot LG, de Guglielmo, Giordano, George, Olivier, Kallupi, Marsida, Kononoff, Jenni, Palmer, Abraham A, Schweitzer, Paul, Solberg Woods, Leah C   +7 more
core  

Perspectives from Systems-Level Key Informants on Optimizing Opioid Use Disorder Treatment for Adolescents and Young Adults

Children
Background/Objectives: Rates of receiving opioid use disorder (OUD) treatment among adolescents and young adults (AYA) aged 16–25 are low. The current study qualitatively analyzed informants’ perspectives regarding the availability of, developmental ...
Jasper Yeh, Crosby Modrowski, Isabel Aguirre, Samantha Portis, Robert Miranda, Melissa Pielech   +5 more
doaj   +1 more source

Stigma as a fundamental hindrance to the United States opioid overdose crisis response. [PDF]

, 2019
Alexander Tsai and co-authors discuss the role of stigma in responses to the US opioid ...
Barnett, Michael L, Beletsky, Leo, Keyes, Katherine M, Kiang, Mathew V, McGinty, Emma E, Smith, Laramie R, Strathdee, Steffanie A, Tsai, Alexander C, Venkataramani, Atheendar S, Wakeman, Sarah E   +9 more
core   +2 more sources

Low barrier medication for opioid use disorder at a federally qualified health center: a retrospective cohort study

Addiction Science & Clinical Practice, 2022
Background Medication for opioid use disorder (MOUD) reduces mortality, but few patients access MOUD. At a Federally Qualified Health Center (FQHC), we implemented a low barrier model of MOUD, including same-day MOUD initiation and a harm reduction ...
Jamie Carter, Zhen Li, Hillary Chen, Melissa Greiner, Christopher Bush, Debanjan Bhattacharya, Stephanie Poley, Nidhi Sachdeva, Jane Carolyn Crowder, Jacob Feigal   +9 more
doaj   +1 more source

Receipt and duration of buprenorphine treatment during pregnancy and postpartum periods in a national privately-insured cohort

Drug and Alcohol Dependence Reports, 2023
Background: Research gaps exist on the use of medications for opioid use disorder (OUD) among birthing people. Methods: This retrospective cohort study included people who underwent childbirth deliveries during 2017-2020 and had a diagnosis of OUD ...
Xi Wang, Zachary Meisel, Katherine Kellom, Jennifer Whitaker, Douglas Strane, Anyun Chatterjee, Rebecka Rosenquist, Meredith Matone   +7 more
doaj   +1 more source

Hepatitis C Education and Screening in a Rural Northern Vermont MAT Clinic [PDF]

, 2020
Increases in hepatitis C infection rates have mirrored increases in opioid use disorder. This project attempted to determine screening rates of HCV in a medication assisted treatment clinic for opioid use disorder.
Fitzsimons, Jack
core   +1 more source

Treatment of Opioid-Use Disorders [PDF]

New England Journal of Medicine, 2016
Opioid-use disorders are common, but most physicians are not trained to recognize and treat them. This review outlines a general approach to identifying and treating these disorders.
Winetsky, Daniel, Weinrieb, Robert M, Perrone, Jeanmarie   +2 more
openaire   +9 more sources

The relationship between reincarceration and treatment of opioid use disorder with extended-release naltrexone among persons with HIV

Drug and Alcohol Dependence Reports, 2023
Background: In the United States, a disproportionate number of persons with HIV (PWH) and opioid use disorder (OUD) are involved in the justice system. Medications for OUD (MOUD) can reduce convictions and incarceration time in persons with OUD. Extended-
Kaley Parchinski, Angela Di Paola, Allison P. Wilson, Sandra A. Springer   +3 more
doaj   +1 more source

A state-level study of opioid use disorder treatment access and neonatal abstinence syndrome [PDF]

, 2019
Background Adult opioid use and neonatal abstinence syndrome (NAS) are growing public health problems in the United States (U.S.). Our objective was to determine how opioid use disorder treatment access impacts the relationship between adult opioid use ...
Abbinanti, Kassie, Krist, Alex H., Pecsok, James, Sabo, Roy T., Tong, Sebastian T., Wolf, Elizabeth R., Woolf, Steven H.   +6 more
core   +1 more source